These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8767988)

  • 1. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombolytic therapy of deep venous thrombosis. Indications, treatment procedures].
    Theiss W
    Internist (Berl); 1992 Apr; 33(4):225-31. PubMed ID: 1612846
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic therapy.
    Collen D; Lijnen HR
    Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies for the improvement of thrombolytic agents.
    Lijnen HR; Collen D
    Thromb Haemost; 1991 Jul; 66(1):88-110. PubMed ID: 1926054
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug variables in thrombolytic therapy.
    Meyerovitz MF
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):62S-65S. PubMed ID: 8770844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic therapy].
    Matsuda T
    Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasminogen activators and thrombolytic therapy].
    Taran LD
    Biomed Khim; 2005; 51(3):248-62. PubMed ID: 16104388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the development of improved thrombolytic agents.
    Lijnen HR; Collen D
    Br J Haematol; 1991 Mar; 77(3):261-6. PubMed ID: 1901494
    [No Abstract]   [Full Text] [Related]  

  • 10. Newer thrombolytic drugs for acute myocardial infarction.
    Reddy DS
    Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraxial bleeding: fibrinolytics/thrombolytics.
    Rosenquist RW; Brown DL
    Reg Anesth Pain Med; 1998; 23(6 Suppl 2):152-6. PubMed ID: 9845388
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases.
    Roudaut R; Lafitte S; Roudaut MF; Courtault C; Perron JM; Jaïs C; Pillois X; Coste P; DeMaria A
    J Am Coll Cardiol; 2003 Feb; 41(4):653-8. PubMed ID: 12598078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolytic therapy in ischemic brain infarct].
    Del Zoppo GJ; Hacke W
    Dtsch Med Wochenschr; 1987 Apr; 112(15):603-8. PubMed ID: 3104001
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombolytic therapy of venous thromboses].
    Heinz M; Theiss W
    Internist (Berl); 1996 Jun; 37(6):567-73. PubMed ID: 8767989
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 17. The ideal fibrinolytic: can drug design improve clinical results?
    Van de Werf FJ
    Eur Heart J; 1999 Oct; 20(20):1452-8. PubMed ID: 10493843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasminogen activators as thrombolytic agents in myocardial infarction].
    Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
    Lijnen HR; Stump DC; Collen DC
    Semin Thromb Hemost; 1987 Apr; 13(2):152-9. PubMed ID: 3114883
    [No Abstract]   [Full Text] [Related]  

  • 20. Combinations of thrombolytic agents in acute myocardial infarction.
    Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
    Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.